Becker's Healthcare September 23, 2022
From new technologies to physician autonomy, here are five leaders’ perspectives on where the GI industry is headed.
Editor’s note: Responses were edited lightly for clarity and brevity.
Latha Alaparthi, MD. President and Chair of the Board of Directors of the Digestive Health Physicians Association (Silver Spring, Md.): In GI, I’m really excited about newer medications, [such as] other modes of delivery where there’s cognitive behavioral therapy or alternative therapies for some of these psychosomatic issues that we tackle on a day-to-day basis and all the [artificial intelligence] and database delivery changes that we may make. I don’t know what the data actually will bring us in terms of interventions that we can change, but I think we are just...
Today's Sponsors
Today's Sponsor